Class Action Lawsuit Filed Against Drug Manufacturer For Manufacturing Error
A class action lawsuit has been filed against the Activis Group, Mylan Pharmaceuticals, in the United States District Court, Eastern District of Michigan, Southern Division. It is the first drug product liability action in a Michigan Court since the Michigan Supreme Court affirmed former Governor Engler’s grant of immunity to drug manufacturers. The name of the drug in question is Digitek(R), the trade name and the brand name is digitalis. The drug is given to the heart patients.
The lawsuit charges that during the manufacturing process, errors were made such that the .125 mg labeled tablet was actually .250 mg; and, the tablet sold as .25 mg was actually .50 mg. This manufacturing error is not covered by the broad grant of immunity Governor Engler intended when Michigan’s drug manufacturer immunity legislation was adopted during the Engler Administration. Death from ventricular arrhythmia, or heart block, can result from digitalis overdose. Non-fatal complications can include nausea, vomiting,severe weight loss, diarrhea, mental confusion, vision changes and elevated
blood pressure, which can lead to cerebral strokes.
The leading plaintiffs are Anthony Harris (Redford) and Steven B. Love (Kentwater).
For more information contact J. Douglas Peters or Ann K. Mandt of Charfoos and Christensen, P.C., at 313.875.8080.
Source: The Earth Times
Filed under Class Action, Medical Malpractice
You may also like to read
- Lawsuit Stops Center for Medicare Advocacy's Efforts To Reclaim Improperly Mailed Medicare Drug Benefit Premium Refunds
- Class Action Lawsuit Settlement for $70 Million by GlaxoSmithKline
- Israeli Citizens File Class Action Against Vioxx
- KV Pharmaceutical faces lawsuit
- United Auto Workers And Freightliner in Class Action Loom
- United Auto Workers And Freightliner in Class Action Loom
- Class Action Lawsuit Filed Against Athol Manufacturing Corp Over Butner Plant Closing
- $150 Million Class Action Settlement by Three Drug Makers
- Lawsuit against drug maker KV Pharmaceutical and subsidiary
- GSK in Class Action Danger Over Anti-depressant Drug Seroxat
